Later in callus development, TSP2 cells were broadly distributed in the undifferentiated callus, but GFP was not expressed by chondrocytes. Flow cytometry confirmed that the majority of TSP2 expressing cells were positive for traditional murine MSC markers. Our in vitro assays further supported these findings by demonstrating all adherent and colony-forming cells expressed TSP2. Taken together, our results suggest that TSP2 is expressed by undifferentiated MSCs, but downregulated in chondrocytes. Clinical significance expression of the matricellular protein TSP2 is a promising new marker to identify MSCs in early fracture healing.The authors describe the problems associated with a twin pregnancy combining a complete vesicular mole and an apparently normal fetus (BJOG 2020 xxxx). The problem is uncommon and the diagnosis may prove challenging. The ultrasound features of this condition can be very similar to those of placental mesenchymal dysplasia (PMD) or a partial vesicular mole.Objectives To assess the presence of self-reactive immune responses to seminal and prostate antigens (PAg), biomarkers of inflammation of the male genital tract and semen quality parameters in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Subjects and methods peripheral blood and semen samples were collected from CP/CPPS patients and age-matched healthy control volunteers. The analysis of lymphoproliferative responses of peripheral blood mononuclear cells (PBMC) to different seminal plasma-derived and purified PAg, serum autoantibodies specific to PAg, leukocyte subpopulations and inflammatory cytokines in semen, sperm apoptosis/necrosis, and semen quality parameters were performed. Results Significantly increased PBMC proliferative responses specific to PAg, with elevated secretion of IFNγ and IL-17, were detected in CP/CPPS patients with respect to controls. Moreover, CP/CPPS patients showed significantly increased serum IgG immune reactivity to seminal plasma proteins such as Prostate Specific Antigen (PSA) and Prostatic Acid Phosphatase (PAP) than controls. Inflammation of the male genital tract was revealed by high levels of IFNγ, IL-17, IL-1β and IL-8, as well as increased counts of leukocytes, mainly CD4 T lymphocytes and macrophages, in semen. In addition, this local inflammation was associated to an overall decreased semen quality; i.e., reduced sperm concentration, motility and viability and increased levels of sperm apoptosis/necrosis were found in CP/CPPS patients with respect to controls. Conclusion CP/CPPS patients show Th1 and Th17 immune responses specific to PAg associated to chronic inflammation of the male genital tract and reduced semen quality. These immune responses may underlie the induction and development of chronic pelvic pain and inflammation of the male genital tract, which in turn could alter the normal prostate functionality and impair semen quality.Background In treating short-bowel syndrome (SBS), autonomy from parenteral nutrition (PN) relies upon intestinal adaptation, which can be augmented by glucagon-like peptide-2 (GLP-2) analogues. In neonatal piglets with SBS, we compared intestinal adaptation following treatment with 2 GLP-2 analogues teduglutide (TED) and apraglutide (APRA) METHODS Following 75% distal small-intestinal resection, piglets were allocated to 4 treatment groups saline (CON n = 8), twice weekly APRA (5 mg/kg/dose; n = 8), and TED once daily (TED, 0.05 mg/kg/dose; n = 8) or twice daily (TEDBID, 0.05 mg/kg/dose; n = 7). Pharmacokinetic (PK) studies were undertaken, and on day 7, small-intestinal length and weight were measured and jejunal tissue collected for histology. Results PK profiles were different between the 2 analogues. To achieve a comparable exposure to APRA, TED requires twice daily injection (TEDBID). Compared with CON, APRA and TEDBID increased small-bowel length (cm) (CON 141, APRA 166, TED 153, TEDBID 165; P = .004), whereas APRA increased small-bowel weight (g) (CON 26, APRA 33, TED 28, TEDBID 31; P = .007) and villus height (mm) (CON 0.59, APRA 0.90, TED 0.58, TEDBID 0.74; P less then .001). Conclusion APRA injected only twice during the 7 consecutive days demonstrated a superior intestinotrophic effect compared with TED injected once daily. Even at more comparable drug exposure, when TED was injected twice a day, APRA showed superior trophic activity at the mucosal level. This is highly relevant for the treatment of pediatric SBS, given the markedly lower dose frequency by subcutaneous injection of APRA.Objectives This manuscript describes policy, systems, and environments (PSE) changes made to support health secondary to a county-based coalition nurse-led program targeting vulnerable populations at five community-based sites in a single rural Midwest county. Design A mixed-methods pre-post approach was used to evaluate the PSE changes occurring over a 1-year period secondary to wellness programming. Sample Five community sites including three predominantly manufacturing worksites and two faith-based sites were included in this study. AZD7648 Measurements The Centers for Disease Control and Prevention Community Health Assessment aNd Group Evaluation tool was used to collect PSE data both at site initiation and 1 year later. Logs kept by program staff which included discussions with site leaders and program participants were also used to measure PSE changes. Intervention Monthly wellness programming which included intentional feedback to site leadership concerning participant feedback and coalition staff observations of the impact of site specific PSEs on healthy lifestyle behaviors. Outcomes Positive changes reflecting improvement in policy and environments were noted for 99.2% of the scores with a total of 13 PSE changes documented across the sites. The greatest change noted related to leadership, indicating increased commitment by site leadership to support health.Interpersonal distance, an essential component of social interaction, is modulated by the emotion conveyed by others and associated physiological response. However, in modern societies with overcrowded and hyperstimulating environments, we can only surreptitiously glimpse the faces of others in order to quickly make behavioral adjustments. How this impacts social interactions is not yet well understood. In the present study, we investigated this issue by testing whether facial expressions that are difficult to identify modify the physiological response (Electrodermal Activity, EDA) and subsequent judgment of interpersonal comfort distance. We recorded participants' EDA while they provided comfort judgments to interpersonal distances with a Point-Light Walker (PLW). The PLW, with an emotionally neutral gait, moved toward and crossed participants at various distances after the latter were exposed to a negative (anger), positive (happiness) or neutral facial expression presented at the perceptual threshold. Bayesian analyses of the data revealed an increase versus decrease of interpersonal comfort distance with the PLW depending on the negative versus positive emotional valence of the facial expression.